Wall Street Journal - October 27, 2008

The European Parliament's awarding last week of its annual Sakharov Prize for Freedom of Thought to Chinese dissident Hu Jia is a positive step in more ways than one.

The award honors "particular achievement in . . . defense of human rights and fundamental freedoms, particularly the right to free expression." Mr. Hu is serving a 3 1/2-year prison sentence for what Beijing calls "incitement to subvert state power." In September last year he and fellow activist Teng Biao published an open letter describing Olympics-related abuses, such as corruption and forced relocations. Mr. Hu testified to the European Parliament via telephone in November, prompting his arrest. He is also well known as an advocate for people suffering from HIV/AIDS.

Beijing had campaigned hard against the award, with Ambassador Song Sze warning in a letter that giving Mr. Hu the prize "would inevitably . . . bring serious damage to China-EU relations." That threat came ahead of the weekend's biennial EU-Asia summit, at which leaders discussed cooperation amid the global financial panic.

Beijing issued a blustery denouncement when the prize was announced Thursday. But the award doesn't appear to have hurt the summit. Canadian Prime Minister Stephen Harper's meeting with the Dalai Lama last year also seems to have done no lasting damage to Sino-Canadian economic ties. This all suggests that since China needs economic cooperation with other countries as much as they need China, foreign leaders have more room than some thought to discuss human rights.

Mr. Hu is a model of courage in the face of Beijing's oppression. Meanwhile, European parliamentarians have helped to show it's possible to push Beijing on freedom in the context of a broader, cooperative, relationship.

081027
WJ081003

Copyright © 2008 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .